Description
LIVMARLI (maralixibat) oral solution and tablets are a prescription medicine used to treat:
- cholestatic pruritus (itch) in patients who are 3 months of age and older with Alagille syndrome
- cholestatic pruritus (itch) in patients who are 12 months of age and older with progressive familial intrahepatic cholestasis (PFIC)
- LIVMARLI is not for use in PFIC type 2 patients who have a severe defect in the bile salt export pump (BSEP) protein
It is not known if LIVMARLI is safe and effective in children with Alagille syndrome who are under 3 months of age. It is not known if LIVMARLI is safe and effective in children with PFIC who are under 12 months of age. It is not known if LIVMARLI is safe and effective in adults who are 65 years of age and older.
Additional information
| Brand | Livmarli |
|---|---|
| Generic name | Maralixibat oral solution |
| Form | Oral solution |
| Strength | 9.5mg/ml |
| Packing | 30ml/pack |
| Manufacturer | Halo pharma |
| Documents | Either PO or prescription |
| Storage | 20-25°C temperature |
Reviews
There are no reviews yet.